TO STUDY EFFICACY AND SAFETY OF CAPSULE IMMUNRICH COMPARED WITH PLACEBO IN PATIENTS WITH RECURRENT UPPER RESPIRATORY TRACT INFECTIONS

Phase 2

Conditions: Health Condition 1: null- Adult patients with recurrent upper respiratory tract infections

Registration Number: CTRI/2015/03/005637

Lead Sponsor: Charak Pharma Pvt Ltd CPP

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Not specified

Target Recruitment: 60

Inclusion Criteria

The participant may enter the trial if ALL of the following apply:

Adult patient of either gender within age range of 18 to 70 years

Participant is willing and able to give informed consent for participation in the trial

Patients with greater than 1 yearâ??s history of recurrent( more than 3 episodes) or chronic upper respiratory infections with the presence of at least two of the following

Rhinitis

Pharyngitis

Cough

Pyrexia with body temperature more than 38.5oC

Participant has clinically acceptable laboratory results

In the Investigatorâ??s opinion, is able and willing to comply with all trial requirements

Exclusion Criteria

The participant may not enter the trial if ANY of the following apply:

Patients suffering from any severe metabolic, neurological or cardiovascular disorder

Patients taking any other medicine on long term basis

Patients suffering from lower respiratory tract infections

Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participant at risk because of participation in the trial, or may influence the result of the trial, or the participantâ??s ability to participate in the trial

Participants who have participated in another research trial involving an investigational product in the past 12 weeks